// App-Quantinova.ai

TCT-455 : Clinical Outcomes in the Percutaneous Coronary Intervention of In-Stent Restenosis with the XIENCE V Everolimus-Eluting Stent

Researchers

Presenter

  • Michael Lee

Principal Investigators

  • Tae Yang

  • Ehtisham Mahmud

  • Kyung Woo Park

  • Hyo-Soo Kim

  • Moo Hyun Kim

  • George Dangas

  • James Hermiller Jr

  • Mitchell Krucoff

  • David Rutledge

Medical Centers

  • University of California, San Diego, La Jolla, CA

  • Henry Ford Hosp, Detroit, MI

  • Mount Sinai, New York City, New York, United States

  • Duke Clinical Research Institute, Durham, NC

Locations

  • United States

Companies

  • Abbott

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Coronary Artery Disease

  • Myocardial infarction

  • Restenosis

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved